Should I Buy PNTG? PNTG 2026 Analysis

Should You Buy Pennant Group Inc (PNTG) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

27.340

1 Day change

-0.55%

52 Week Range

31.940

Analysis Updated At

2026/01/26

Pennant Group Inc (PNTG) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 to invest. The stock demonstrates strong technical indicators, positive analyst sentiment, and a favorable long-term growth outlook, despite minor financial setbacks in the latest quarter.

Technical Analysis

The technical indicators are bullish. The MACD is positive and expanding (0.159), RSI is neutral at 63.869, and moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200). The stock is trading above its pivot point (29.677) with resistance levels at 31.323 and 32.34, indicating potential upward movement.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

Positive analyst sentiment with multiple upgrades and increased price targets (ranging from $31 to $40). The clearing of regulatory overhangs and favorable reimbursement outlooks are seen as strong growth drivers. Additionally, the Amedisys acquisition is expected to enhance growth potential.

Neutral/Negative Catalysts

The latest financial quarter showed a decline in net income (-2.00% YoY), EPS (-15.00% YoY), and gross margin (-0.16% YoY), which could indicate short-term challenges.

Financial Performance

In Q3 2025, revenue increased significantly by 26.76% YoY to $229.04M, reflecting strong top-line growth. However, net income dropped to $6.08M (-2.00% YoY), and EPS fell to 0.17 (-15.00% YoY), indicating margin pressure.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are highly positive on PNTG, with multiple upgrades and price target increases. Recent price targets range from $31 to $40, with firms citing strong sector trends, favorable reimbursement outlooks, and M&A momentum as key drivers.

6 Analyst Rating

Wall Street analysts forecast PNTG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PNTG is 37.6 USD with a low forecast of 34 USD and a high forecast of 40 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Buy

0 Hold

0 Sell

Strong Buy

Current: 27.490

Low

Averages

37.6

High

Current: 27.490

Low

Averages

37.6

High

Wells Fargo

Stephen Baxter

Overweight

maintain

$31 -> $38

AI Analysis

2026-01-07

Reason

Wells Fargo

Stephen Baxter

Price Target

$31 -> $38

AI Analysis

2026-01-07

maintain

Overweight

Reason

Wells Fargo analyst Stephen Baxter raised the firm's price target on Pennant Group to $38 from $31 and keeps an Overweight rating on the shares. For managed care organizations, the firm is most constructive on Medicare Advantage with uncertainty high for Medicaid/Exchanges. Wells sees a more difficult backdrop for hospitals in 2026 as post-COVID tailwinds wane and legislative risks near. Distributor debate remains revisions vs. multiples.

Jefferies

Buy

upgrade

$30 -> $40

2025-12-16

Reason

Jefferies

Price Target

$30 -> $40

2025-12-16

upgrade

Buy

Reason

Jefferies raised the firm's price target on Pennant Group to $40 from $30 and keeps a Buy rating on the shares. The firm raised its price target to reflect the clearing of the final home health rule overhang, the analyst tells investors.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for PNTG

Unlock Now

PNTG Should I Buy

PNTG Should I Buy

Should You Buy Pennant Group Inc (PNTG) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch